| Target Price | $4.08 |
| Price | $0.56 |
| Potential |
632.50%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Plus Therapeutics Inc 2026 .
The average Plus Therapeutics Inc target price is $4.08.
This is
632.50%
register free of charge
$22.05
3,858.71%
register free of charge
$3.03
443.99%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Plus Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Plus Therapeutics Inc stock has an average upside potential 2026 of
632.50%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 22 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 21 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Oct 06 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 22 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


